Why is Emcure Pharma falling/rising?

As of 22-Jul, Emcure Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 1,425.40, reflecting a rise of Rs 68.4 or 5.04%. The stock has outperformed its sector by 5.95% today and has reached an intraday high of Rs 1,425.40. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Despite a significant drop in delivery volume by 63.03% compared to the 5-day average, the company has demonstrated high management efficiency with a return on capital employed (ROCE) of 20.07% and a low debt-to-EBITDA ratio of 1.00 times. Additionally, Emcure has reported positive results for the last three consecutive quarters, with net sales reaching Rs 2,116.25 crore, contributing to the stock's favorable performance.
In the broader market context, Emcure Pharmaceuticals has shown a 4.51% increase over the past week, while the Sensex has declined by 0.47%, indicating that the stock is performing well relative to the market. Over the past month, Emcure's stock has risen by 8.80%, contrasting with a slight decrease in the Sensex of 0.27%. Although the year-to-date performance shows a slight decline of 0.88% for Emcure compared to a 5.18% increase in the Sensex, the recent quarterly results and strong financial metrics suggest that the stock is gaining traction, likely contributing to its current upward movement.